GETTING UNDER THE SKIN

Summary from the TLDR newsletter

Three scientists are engineering skin microbes into a diffuse network of continuous glucose monitors and insulin factories inside the body. The approach could provide a new option for people living with diabetes and create fierce competition in the largely monopolized insulin industry. This article discusses the insulin industry, how the scientists developed their treatment, and the road ahead for the research.